| 14:48 | Sermonix to Host Virtual Clinical Update on its ELAINE Phase 2 Clinical Programs |  |
| 08/08 | Lilly's Taltz® (ixekizumab) Now Available in New, Citrate-Free Formulation to Reduce In.. | |
| 08/08 | Eli Lilly and Company Announces the Availability of a New, Citrate-Free Formulation of .. | |
| 08/08 | Eli Lilly May Divert Employment Outside Indiana After US State OKs Abortion Bill | |
| 06/08 | Biden team, Eli Lilly condemn new Indiana abortion ban | |
| 05/08 | Eli Lilly Stock Outlook Unchanged After Q2 Update But 'Mixed Elements' to Consider, Gol.. | |
| 05/08 | PUMP / DUMP #40 : This week's gainers and losers | |
| 05/08 | Another case of good news is bad news | |
| 04/08 | MÄRKTE USA/Wall Street uneinheitlich - Ölpreise im freien Fall |  |
| 04/08 | ELI LILLY & CO Management's Discussion and Analysis of Results of Operations and
Finan.. | |
| 04/08 | GLOBAL MARKETS LIVE : Bayer, Merck, eBay, MetLife, Eli Lilly... | |
| 04/08 | TRANSCRIPT : Eli Lilly and Company, Q2 2022 Earnings Call, Aug 04, 2022 | |
| 04/08 | Eli Lilly Lowers 2022 Profit Outlook on Foreign Exchange Headwinds as Second-Quarter Re.. | |
| 04/08 | Lilly Updates Conference Call Start Time for Second-Quarter 2022 Financial Results | |
| 04/08 | SECTOR UPDATE : Health Care Stocks Mixed Pre-Bell Thursday | |
| 04/08 | Still seeing the glass half full | |
| 04/08 | El fármaco contra el Alzheimer de Lilly podría obtener una rápida aprobación de la FDA .. |  |
| 04/08 | SECTOR UPDATE : Health Care | |
| 04/08 | MARKETSCREENER'S WORLD PRESS REVIEW : August 4, 2022 | |
| 04/08 | ELI LILLY AND : Q2 2022 Financial Workbook | |
| 04/08 | ELI LILLY AND : Lilly Reports Second-Quarter Financial Results, Highlights Momentum of New.. | |
| 04/08 | Eli Lilly Trims FY22 EPS Guidance Amid Weaker Q2 Results | |
| 04/08 | Eli Lilly verlaagt outlook weer |  |
| 04/08 | Eli Lilly and Company's Q2 Adjusted Earnings, Revenue Fall | |
| 04/08 | ELI LILLY AND : Q2 2022 Lilly Press Release | |
| 04/08 | LILLY : Q2 Earnings Snapshot | |
| 04/08 | Eli Lilly quarterly profit falls 31% on diabetes drug weakness | |
| 04/08 | GUIDANCE : (LLY) ELI LILLY AND COMPANY Expects Fiscal Year 2022 EPS Range $7.90 - $8.05 | |
| 04/08 | Lilly Reports Second-Quarter Financial Results, Highlights Momentum of New Medicines an.. | |
| 04/08 | Earnings Flash (LLY) ELI LILLY AND COMPANY Posts Q2 Revenue $6.49B | |
| 04/08 | Earnings Flash (LLY) ELI LILLY AND COMPANY Reports Q2 EPS $1.25 | |
| 04/08 | Eli Lilly and Company Revises Earnings Guidance for the Year 2022 | |
| 04/08 | BOLSA DE MADRID : La tecnología está cansada de ir cuesta abajo | |
| 04/08 | Eli Lilly Seeks US Approval for Direct Sale of COVID-19 Antibody to Healthcare Faciliti.. | |
| 03/08 | Eli Lilly to make COVID-19 antibody drug commercially available from August | |
| 03/08 | Eli Lilly Says Intends To Make Bebtelovimab Commercially Available For Purchase By U.S... | |
| 01/08 | Optimism returns | |
| 01/08 | BOLSA DE MADRID : Fuegos de artificio en julio | |
| 22/07 | Lilly's Diabetes Drug Mounjaro Gets EU Medicines Agency Panel's Recommendation | |
| 21/07 | Lilly Confirms Date and Conference Call for Second-Quarter 2022 Financial Results Annou.. | |
| 20/07 | Auron Therapeutics, Inc. announced that it has received $48 million in funding from a g.. | |
| 18/07 | Erasca Working With Eli Lilly in Oncology Clinical Trial | |
| 18/07 | Delfi Diagnostics, Inc. announced that it has received $224.999901 million in funding f.. | |
| 14/07 | Triastek Announces Research Collaboration with Lilly to Explore the Application of 3D P.. | |
| 14/07 | Auron Therapeutics, Inc. announced that it expects to receive funding | |
| 12/07 | Investors are bracing for earnings season | |
| 12/07 | ANALYST RECOMMENDATIONS : Blackrock, Eli Lilly, Hammerson, Mondelez, Twitter... | |
| 01/07 | Pharmaceutical companies still have the upper hand | |
| 29/06 | GLOBAL MARKETS LIVE : Novartis, Tesla, Disney, Sony, Walmart... | |
| 29/06 | Eli Lilly and Company to Supply an Additional 150,000 Doses of Abcellera-Discovered Ant.. | |
| 29/06 | Confidence is key | |
| 29/06 | Eli Lilly Bags $275 Million Deal to Supply Additional Doses Of COVID-19 Antibody Drug i.. | |
| 29/06 | Eli Lilly to Provide US Government With Additional 150,000 Doses of COVID-19 Treatment .. | |
| 29/06 | Lilly will supply an additional 150,000 doses of bebtelovimab to U.S. government in ong.. | |
| 29/06 | Eli Lilly and Company Will Supply an Additional 150,000 Doses of Bebtelovimab to U.S. G.. | |
| 29/06 | Eli Lilly Gets $275 Million U.S. Pact for Covid-19 Antibody Drug | |
| 27/06 | Lilly Declares Third-Quarter 2022 Dividend | |
| 27/06 | Eli Lilly and Company Declares Third-Quarter Dividend for 2022, Payable on September 9,.. | |
| 27/06 | Eli Lilly, Innovent's Tyvyt Obtains Approval to Treat Advanced Gastric, Gastroesophagea.. | |
| 27/06 | Innovent Biologics, Inc. and Eli Lilly and Company Jointly Announces Approval of TYVYT .. | |
| 22/06 | AVEO Pharmaceuticals, Eli Lilly Partner in Clinical Trial to Assess Potential Treatment.. | |
| 22/06 | Aveo Pharmaceuticals, Inc. Announces Clinical Trial Collaboration and Supply Agreement .. | |
| 22/06 | AVEO Oncology in Collaboration, Supply Agreement With Eli Lilly | |
| 21/06 | Eli Lilly, Innovent's Tyvyt Gets Approval for Treatment of Esophageal Cancer in China | |
| 21/06 | Innovent and Lilly Jointly Announce the Approval of TYVYT (sintilimab injection) by Chi.. | |
| 17/06 | Sidekick Enters Strategic Collaboration with Lilly to Support Patients with Breast Canc.. | |
| 14/06 | TRANSCRIPT : Eli Lilly and Company Presents at Goldman Sachs 43rd Annual Global Healthcare.. | |
| 14/06 | Eli-Lilly-Medikament gegen Kreisrunden Haarausfall in USA zugelassen | |
| 14/06 | Eli Lilly, Incyte Win US FDA Approval For Alopecia Areata Treatment | |
| 14/06 | Eli Lilly, Incyte Say FDA Approves Olumiant for Treatment of Alopecia Areata in Adults | |
| 13/06 | FDA Grants the Approval of First Systemic Treatment for Alopecia Areata to Eli Lilly an.. | |
| 13/06 | Eli Lilly Signs License Deal With DE Shaw Research | |
| 13/06 | FDA Approves Eli Lilly's Olumiant Oral Tablets for Alopecia | |
| 10/06 | Sermonix to Host Virtual Clinical Update on its ELAINE Phase 2 Clinical Programs | |
| 10/06 | Delfi Diagnostics, Inc. announced that it expects to receive $224.999901 million in fun.. | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
